术后的心脏生物标志物释放在具有或没有冷凝的最小侵入性AV门手术后
Jang-Sun Lee1, Dilara M Berberoglu1, Majd Ismail1
1Department of Cardiac Surgery, Kerckhoff Clinic, Germany, University Hospital of Giessen, Bad Nauheim, Giessen, Germany.
The Thoracic and cardiovascular surgeon
|November 19, 2025
概括
在最小侵入性门手术期间同时进行冷,会显著提高心脏生物标志物,如素T. 然而,临床术后心肌梗塞发病率仍然很低,这表明需要程序特定的诊断标准.
科学领域:
- 心脏病学 心脏病学
- 心脏外科手术 心脏外科手术
- 生物标记分析 生物标记分析
背景情况:
- 对于心房动的同时进行冷,在微创性心房 (AV) 门手术期间是常见的.
- 在冠状动脉旁路手术后,术后心肌梗塞 (pMI) 已确定的生物标志物值可能不适用于带冷的内镜门手术.
研究的目的:
- 为了分析经术期间心脏生物标志物释放模式,在接受内镜AV门手术的患者中进行或不进行冷.
- 评估心血管血管图谱和干预学会 (SCAI) 定义的pMI值在这个特定患者队列中的适用性.
主要方法:
- 在2018年至2024年期间接受了内镜性AV门手术的患者的回顾性分析.
- 在冷却和非冷却组之间对外科手术期间肌动脉激酶-肌动脉带 (CK-MB) 和素T (TnT) 水平进行比较.
- 对住院结果的评估和生物标志物水平与SCAI pMI标准的比较.
主要成果:
- 与非冷化组相比,冷化组显著增加了CK-MB (6.4x ULN) 和TnT (257x ULN) 相比,非冷化组的CK-MB (6.4x ULN) 和TnT (80x ULN) 分别增加了2.4x ULN和80x ULN).
- 虽然CK-MB仍然低于SCAI pMI值,但TnT在冷却组中经常超过它们 (p <0.05).
- 尽管生物标志物升高,临床pMI率很低,在各组之间没有显著差异;住院死亡率也没有显著差异.
结论:
- 在微创性AV门手术期间的冷会导致术后心脏生物标志物大幅增加.
- 由于TnT水平升高,目前的SCAI对pMI的标准可能会高估由于受冷治疗的患者的心脏病发作.
- 开发特定程序的生物标志物值对于准确的诊断和管理这一患者群体至关重要.
更多相关视频
相关概念视频
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
769
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
769
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
522
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
522